Workshop

European Molecular Biology Organization

HEDGEHOG SIGNALING:

From developmental biology

to anti-cancer drugs

 

 

 

 

 



27 - 31 March | 2010 |St. Jean Cap Ferrat| France

Speakers

 

F. Aberger  University of Salzburg Salzburg Austria
K. Anderson  Sloan-Kettering Institute  New York   USA
P. A. Beachy  Stanford University  Stanford USA
J. Briscoe  NIMR  London  UK
F. Charron  IRCM  Montréal  Canada
P.-T. Chuang  UCSF  San Francisco  USA
F. de Sauvage  Genentech Inc  San Francisco  USA
S. Eaton  Max Planck Institute  Dresden  Germany
I. Guerrero  Universidad Autonoma de Madrid Madrid Spain
A. Gulino  University La Sapienza  Rome  Italy
P. W. Ingham  IMCB  Singapore Singapore
J.  Jiang  UT Southwestern Medical Center  Dallas  USA
L. Joyner

Memorial Sloan-Kettering Cancer Center

 New York  USA
T. Kornberg  UCSF  San Francisco  USA
X. Lin  Cincinnati Children's Hospital  Cincinatti USA
E. Marti  CSIC  Barcelona  Spain
S. Mayor  Tata Institute  Bangalore  India
A. P. McMahon  Harvard University  Cambridge  USA
P. Mehlen  Centre Léon Bérard  Lyon  France
A. Oro  Stanford University Stanford USA
M. Perron  Université Paris XI  Orsay  France
A. Plessis  Jacques Monod Institute  Paris  France
J. Reiter  UCSF  San Francisco  USA
D. J. Robbins  Dartmouth Medical School  Hanover  USA
H.  Roelink  University of Washington  Seattle  USA 
A. Ruiz i Altaba  University of Geneva Geneva Switzerland
M. P. Scott  Stanford University Stanford USA
P. P. Thérond  IBDC  Nice  France
C. Tickle  University of Dundee  Dundee UK
R. Toftgard  Karolinska Institute Stockholm  Sweden
Pending:
Konrad Basler  University of Zurich  Zurich  Switzerland
Sam Kunes  Harvard University  Cambridge  USA 



European Molecular Biology Organization | Meyerhofstrasse 1 | 69117 Heidelberg | Germany